| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |